Beyond its FDA-approved transplant indications, MMF has demonstrated efficacy as a steroid-sparing agent in several autoimmune diseases, including lupus nephritis, autoimmune hepatitis, ANCA-associated vasculitis, inflammatory myopathies, and immune thrombocytopenia, supported by randomized clinical trials and international treatment guidelines
Several licensed options are currently available in the UK, including semaglutide 2.4 mg (Wegovy), tirzepatide (Mounjaro), orlistat, liraglutide 3 mg (Saxenda), and naltrexone/bupropion (Mysimba)
Many users report that the benefits become more noticeable the longer they use it consistently
When the body is under strain, it may divert resources away from what the body classifies as non-essential systems
By working with all key players, LegitScript helps to foster a safer online environment for consumers